GTJ — Antisera, All Groups, N. Meningitidis Class II

FDA Device Classification

FDA product code GTJ covers "Antisera, All Groups, N. Meningitidis", a Class II medical device regulated under 21 CFR 866.3390. Submissions are reviewed by the Microbiology panel. At least 16 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
GTJ
Device Class
Class II
Regulation Number
866.3390
Submission Type
510(k)
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K952791Bd Becton Dickinson Vacutainer Systems PreanalyticDIRECTIGEN MENINGITIS COMBO TESTMay 30, 1996
K915330Bd Becton Dickinson Vacutainer Systems PreanalyticDIRECTIGEN MENINGITIS COMBO TEST KITMar 23, 1992
K910210Vitek SystemsSLIDEX MENINGITE-KIT 5Aug 12, 1991
K885004ArmkelBACTIGEN(R) N. MENINGITIDISFeb 7, 1989
K870089Microscan Div. Baxter HealthcareIMMUNOSCAN(TM) DIRECT NEISSERIA MENINGITIDIS KITMar 17, 1987
K854852Wellcome DiagnosticsWELLCOGEN BACTERIAL ANTIGEN KITFeb 4, 1986
K854851Wellcome DiagnosticsWELLCOGEN N. MENINGITIDIS B/E. COLI K1 ZL24Feb 4, 1986
K844999PharmaciaPHADEBACT CSF TESTOct 17, 1985
K851691Wellcome DiagnosticsWILLCOGEN MENINGITIDIS KIT ZL25Jun 10, 1985
K844762Wellcome DiagnosticsMENINGOCOCCUS GROUP B MONOCLONAL ANTIBODY ZM-51Jun 4, 1985
K844407Bd Becton Dickinson Vacutainer Systems PreanalyticDIRECTIGEN NEISSENA MENNINGITIDIS GROUP B TESTJan 25, 1985
K841907ArmkelBACTIGEN - N.MENNINIGITIDIS TESTJul 6, 1984
K833063Wellcome DiagnosticsWELLCOGEN N. MENINGITIDIS A,C,Y W135Jan 10, 1984
K823880ArmkelBACTIGEN-N. MENINGITIDISMar 9, 1983
K822810PharmaciaPHADEBACT CSF TEST 20Dec 30, 1982
K771562Burroughs WellcomeAGGLUTINATING SERUM W135Aug 25, 1977

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.